Zezhong Liu

5PUBLICATIONS
39CO-AUTHORS
NanomaterialsFunctional materialsCancer therapy (excl. chemotherapy and radiation therapy)Veterinary virologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.

|Apr 16, 2026
Rational Design of Broad-Spectrum Anti-Enteroviral Molecular Glues Targeting Enteroviral RNAi Suppressors.

|Mar 10, 2023
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.

Zezhong Liu, Jie Zhou, Xinling Wang

|Mar 26, 2022
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant.

Naru Zhang, Qianting Ji, Zezhong Liu

|Sep 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.

Zezhong Liu, Wei Xu, Zhenguo Chen

Pageof 1

Frequent Collaborators

4 joint publications

Lu Lu

3 joint publications

Shibo Jiang

1 joint publications

Wei Xu

1 joint publications

Zhenguo Chen